DE69220113T2 - Verfahren zur Herstellung von menschlichem Serum Albumin - Google Patents

Verfahren zur Herstellung von menschlichem Serum Albumin

Info

Publication number
DE69220113T2
DE69220113T2 DE69220113T DE69220113T DE69220113T2 DE 69220113 T2 DE69220113 T2 DE 69220113T2 DE 69220113 T DE69220113 T DE 69220113T DE 69220113 T DE69220113 T DE 69220113T DE 69220113 T2 DE69220113 T2 DE 69220113T2
Authority
DE
Germany
Prior art keywords
serum albumin
human serum
medium
hsa
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69220113T
Other languages
German (de)
English (en)
Other versions
DE69220113D1 (de
Inventor
Hirotoshi Fukutsuka
Kaoru Kobayashi
Shinobu Kuwae
Takao Ohmura
Wataru Ohtani
Tomoshi Ooya
Akinori Sumi
Kazumasa Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of DE69220113D1 publication Critical patent/DE69220113D1/de
Application granted granted Critical
Publication of DE69220113T2 publication Critical patent/DE69220113T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69220113T 1991-03-20 1992-03-18 Verfahren zur Herstellung von menschlichem Serum Albumin Expired - Fee Related DE69220113T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3081719A JPH0671432B2 (ja) 1991-03-20 1991-03-20 ヒト血清アルブミンの製造方法

Publications (2)

Publication Number Publication Date
DE69220113D1 DE69220113D1 (de) 1997-07-10
DE69220113T2 true DE69220113T2 (de) 1997-09-25

Family

ID=13754223

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69220113T Expired - Fee Related DE69220113T2 (de) 1991-03-20 1992-03-18 Verfahren zur Herstellung von menschlichem Serum Albumin

Country Status (9)

Country Link
US (1) US5334512A (OSRAM)
EP (1) EP0504823B1 (OSRAM)
JP (1) JPH0671432B2 (OSRAM)
KR (1) KR100218853B1 (OSRAM)
CA (1) CA2063511C (OSRAM)
DE (1) DE69220113T2 (OSRAM)
DK (1) DK0504823T3 (OSRAM)
ES (1) ES2102420T3 (OSRAM)
TW (1) TW198683B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
CA2136564C (en) * 1993-11-26 2008-04-08 Kaoru Kobayashi Process for producing human serum albumin
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
PL335975A1 (en) 1997-04-03 2000-06-05 Yoshitomi Pharmaceutical Method of obtaining a heterologous protein
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
US8263401B2 (en) * 2004-05-26 2012-09-11 University Of Medicine And Dentistry Of New Jersey Adenylyl cyclase antibodies, compositions and uses thereof
WO2006066595A2 (en) * 2004-12-22 2006-06-29 Novozymes A/S Recombinant production of serum albumin
NZ602479A (en) 2008-05-15 2013-05-31 R Tech Ueno Ltd Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
CA3047523A1 (en) * 2016-12-21 2018-06-28 Prometic Biosciences Inc. Methods and compositions for preventing or minimizing epithelial-mesenchymal transition
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US12151045B2 (en) 2020-12-28 2024-11-26 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
KR20240032272A (ko) 2022-09-02 2024-03-12 조신아 아동원예지도사 교육방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
EP0079739A3 (en) * 1981-11-12 1984-08-08 The Upjohn Company Albumin-based nucleotides, their replication and use, and plasmids for use therein
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
EP0206733A1 (en) * 1985-06-17 1986-12-30 Genex Corporation Cloned human serum albumin gene
DK13087A (da) * 1986-01-13 1987-07-14 Genex Corp Gensekvens til fremstilling af human serumalbumin i bacillus
GB8613388D0 (en) * 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
JPS6460370A (en) * 1987-05-27 1989-03-07 Sankyo Co High-temperature culture of yeast
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
JP2791418B2 (ja) * 1987-12-02 1998-08-27 株式会社ミドリ十字 異種蛋白質の製造方法、組換えｄｎａ、形質転換体
JPH01240191A (ja) * 1988-02-16 1989-09-25 Green Cross Corp:The 酵母で機能する新規シグナルペプチドおよびこれを用いた異種蛋白質の分泌発現
IL89992A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
GB8820951D0 (en) * 1988-09-07 1988-10-05 Delta Biotechnology Ltd Fermentation method
CA2017176A1 (en) * 1989-05-22 1990-11-22 Yoshitomi Pharmaceutical Industries Ltd. Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
JP2855130B2 (ja) * 1989-07-19 1999-02-10 吉富製薬株式会社 異種蛋白発現用融合酵母菌、該菌の製造方法および異種蛋白の製造方法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法

Also Published As

Publication number Publication date
DE69220113D1 (de) 1997-07-10
ES2102420T3 (es) 1997-08-01
EP0504823A3 (en) 1993-04-07
EP0504823A2 (en) 1992-09-23
TW198683B (OSRAM) 1993-01-21
KR100218853B1 (ko) 1999-10-01
CA2063511A1 (en) 1992-09-21
CA2063511C (en) 2001-11-27
JPH04293495A (ja) 1992-10-19
US5334512A (en) 1994-08-02
EP0504823B1 (en) 1997-06-04
KR920018218A (ko) 1992-10-21
JPH0671432B2 (ja) 1994-09-14
DK0504823T3 (da) 1997-06-23

Similar Documents

Publication Publication Date Title
DE69130089T2 (de) Hemmung der menschlichen Serumalbuminfärbung
DE69220113T2 (de) Verfahren zur Herstellung von menschlichem Serum Albumin
DE69532603T2 (de) Hefestämme und modifizierte albumine
DE69331507T2 (de) Verfahren zur Reinigung von menschlichem, rekombinantem Serumalbumin
DE69532492T2 (de) Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
DE3876401T2 (de) N-terminale fragmente von menschlichem serumalbumin.
DE69224768T2 (de) Expression von menschlichen Serum-Albuminen in Pichia pastoris
DE69005959T2 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE3888789T2 (de) Mikroorganismus mit geringer Fähigkeit zur Acetat-Bildung und Verfahren zur Herstellung nützlicher Substrate unter Verwendung dieses Mikroorganismus.
DE69329841T2 (de) Verfahren zur Unterdrückung der Koloration von menschlichem Serum-Albumin
DE69318909T2 (de) Verfahren zur Herstellung von menschlichem Wachstumshormon
DE3486359T2 (de) Verfahren zur Herstellung von Riboflavin.
DE68907166T2 (de) Verfahren zur Herstellung von menschlichem Lysozym.
DE69102640T2 (de) Verfahren zur herstellung von einer proteinhaltigen zusammensetzung.
DE69431097T2 (de) Verfahren zur Herstellung von humanem Serumalbumin
DE3878410T2 (de) Verfahren zur erhoehung von gen-expression.
DE69434126T3 (de) Verfahren zum Entfärben von menschlichemn Serum-Albumin
EP0300425B1 (de) Verfahren zur Herstellung von Proteinen in löslicher Form
DE69832709T2 (de) Verfahren zur herstellung von fremden proteinen
DE3689174T2 (de) Verfahren zur Herstellung von Riboflavin.
EP1280893B1 (de) Verfahren zum herstellen von proteinen in einer hefe der gattung arxula und dafür geeignete promotoren
DE3687796T2 (de) Verkuerzter phosphoglycerat-kinase-promotor.
DE1517732C3 (de) Mikrobiologisches Verfahren zur Herstellung hochaktiver Protease
DE69116198T2 (de) Verfahren zur Herstellung von D-Isocitronensäure durch Fermentation
DE69121159T2 (de) Wirt-Vektor-System

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD., OSAKA,

8327 Change in the person/name/address of the patent owner

Owner name: WELFIDE CORP., OSAKA, JP

8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PHARMA CORP., OSAKA, JP

8339 Ceased/non-payment of the annual fee